Morcillo-MartÃn-Romo, P.; Valverde-Pozo, J.; Ortiz-Bueno, M.; Arnone, M.; Espinar-Barranco, L.; Espinar-Barranco, C.; GarcÃa-Rubiño, M.E.
The Role of NK Cells in Cancer Immunotherapy: Mechanisms, Evasion Strategies, and Therapeutic Advances. Biomedicines 2025, 13, 857.
https://doi.org/10.3390/biomedicines13040857
AMA Style
Morcillo-MartÃn-Romo P, Valverde-Pozo J, Ortiz-Bueno M, Arnone M, Espinar-Barranco L, Espinar-Barranco C, GarcÃa-Rubiño ME.
The Role of NK Cells in Cancer Immunotherapy: Mechanisms, Evasion Strategies, and Therapeutic Advances. Biomedicines. 2025; 13(4):857.
https://doi.org/10.3390/biomedicines13040857
Chicago/Turabian Style
Morcillo-MartÃn-Romo, Paula, Javier Valverde-Pozo, MarÃa Ortiz-Bueno, Maurizio Arnone, Laura Espinar-Barranco, Celia Espinar-Barranco, and MarÃa Eugenia GarcÃa-Rubiño.
2025. "The Role of NK Cells in Cancer Immunotherapy: Mechanisms, Evasion Strategies, and Therapeutic Advances" Biomedicines 13, no. 4: 857.
https://doi.org/10.3390/biomedicines13040857
APA Style
Morcillo-MartÃn-Romo, P., Valverde-Pozo, J., Ortiz-Bueno, M., Arnone, M., Espinar-Barranco, L., Espinar-Barranco, C., & GarcÃa-Rubiño, M. E.
(2025). The Role of NK Cells in Cancer Immunotherapy: Mechanisms, Evasion Strategies, and Therapeutic Advances. Biomedicines, 13(4), 857.
https://doi.org/10.3390/biomedicines13040857
